SUNESIS PHARMACEUTICALS INC's ticker is SNSS and the CUSIP is 867328601. A total of 74 filers reported holding SUNESIS PHARMACEUTICALS INC in Q2 2013. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2015 | $139,000 | -50.7% | 45,936 | -60.0% | 0.00% | – |
| Q1 2015 | $282,000 | +51.6% | 114,928 | +58.3% | 0.00% | – |
| Q4 2014 | $186,000 | -76.8% | 72,600 | -35.3% | 0.00% | -100.0% |
| Q3 2014 | $801,000 | +11.9% | 112,169 | +2.2% | 0.00% | 0.0% |
| Q2 2014 | $716,000 | +18.3% | 109,731 | +20.1% | 0.00% | 0.0% |
| Q1 2014 | $605,000 | +74.4% | 91,399 | +25.0% | 0.00% | 0.0% |
| Q4 2013 | $347,000 | +30.0% | 73,119 | +37.7% | 0.00% | 0.0% |
| Q3 2013 | $267,000 | -16.8% | 53,101 | -8.8% | 0.00% | 0.0% |
| Q2 2013 | $321,000 | – | 58,209 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lamond Capital Partners LLC | 1,320,000 | $9,425,000 | 10.46% |
| RA Capital Management | 4,869,261 | $34,767,000 | 4.11% |
| GREAT POINT PARTNERS LLC | 400,000 | $2,856,000 | 1.23% |
| Healthcare Value Capital, LLC | 100,000 | $714,000 | 0.69% |
| DSC Advisors, L.P. | 175,000 | $1,250,000 | 0.63% |
| Quantitative Systematic Strategies LLC | 107,416 | $803,000 | 0.47% |
| Visium Asset Management, LP | 4,093,890 | $29,230,000 | 0.43% |
| Rhenman & Partners Asset Management AB | 201,171 | $1,436,000 | 0.42% |
| EAM Investors, LLC | 277,807 | $1,984,000 | 0.40% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 354,861 | $2,534,000 | 0.39% |